Outcomes of second‐line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials
暂无分享，去创建一个
O. Bairey | A. Polliack | N. Goldschmidt | Y. Herishanu | E. Joffe | L. Shvidel | T. Tadmor | N. Rahimi-Levene | U. Greenbaum | A. Aviv | R. Ruchlemer | R. Fineman | A. Braester | A. Arad